Nifty
Sensex
:
:
23140.50
73895.74
77.40 (0.34%)
315.20 (0.43%)

Pharmaceuticals & Drugs - Domestic

Rating :
65/99

BSE: 500488 | NSE: ABBOTINDIA

26955.00
25-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  26860
  •  27095
  •  26860
  •  26860.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2263
  •  60987595
  •  30655
  •  25135

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 57,236.69
  • 35.45
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 54,981.74
  • 2.44%
  • 11.06

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.99%
  • 0.71%
  • 13.41%
  • FII
  • DII
  • Others
  • 0.38%
  • 8.57%
  • 1.94%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.09
  • 7.12
  • 5.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.95
  • 11.81
  • 5.40

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.82
  • 14.21
  • 8.92

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 48.48
  • 48.00
  • 46.52

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.81
  • 15.05
  • 15.10

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.14
  • 31.83
  • 30.98

Earnings Forecasts:

(Updated: 21-09-2026)
Description
2026
2027
2028
2029
Adj EPS
730.36
812.21
904.03
1008.29
P/E Ratio
36.91
33.19
29.82
26.73
Revenue
6929.05
7488.13
8201.36
8967.3
EBITDA
1892.08
2102.74
2344.1
2612.6
Net Income
1552.02
1725.93
1921.07
2142.58
ROA
24.99
25.29
25.95
25.14
P/B Ratio
12.00
11.19
9.79
8.55
ROE
34.46
34.55
34.88
35.01
FCFF
1644.71
1781.01
1749.09
1923.7
FCFF Yield
3.1
3.36
3.3
3.63
Net Debt
-2082.96
-2791.63
-3314.6
-3109.1
BVPS
2246.68
2409.14
2753.32
3152.27

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Nov 01
Net Sales
-
356.31
Net Sales Growth
-
 
Cost Of Goods Sold
-
182.40
Gross Profit
-
173.91
GP Margin
-
48.81%
Total Expenditure
-
305.87
Power & Fuel Cost
-
2.92
% Of Sales
-
0.82%
Employee Cost
-
21.63
% Of Sales
-
6.07%
Manufacturing Exp.
-
16.42
% Of Sales
-
4.61%
General & Admin Exp.
-
9.79
% Of Sales
-
2.75%
Selling & Distn. Exp.
-
63.11
% Of Sales
-
17.71%
Miscellaneous Exp.
-
9.59
% Of Sales
-
2.69%
EBITDA
-
50.44
EBITDA Margin
-
14.16%
Other Income
-
20.48
Interest
-
0.12
Depreciation
-
4.48
PBT
-
66.33
Tax
-
16.67
Tax Rate
-
25.13%
PAT
-
49.66
PAT before Minority Interest
-
49.66
Minority Interest
-
0.00
PAT Margin
-
13.94%
PAT Growth
-
 
EPS
-
23.42

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.